Compass Pathways Plc (CMPS)
13.06
+1.14
(+9.56%)
USD |
NASDAQ |
May 29, 16:00
12.97
-0.09
(-0.69%)
After-Hours: 20:00
Compass Pathways EPS Diluted (Quarterly) : -0.3044 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Silence Therapeutics Plc | -0.1055 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -1.28 |
| Mereo BioPharma Group Plc | -0.0418 |
| Definium Therapeutics, Inc. | -0.7087 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 77.50M |
| Total Expenses (Quarterly) | -77.50M |
| Enterprise Value | 1.349B |
| Earnings Yield | -24.18% |
| Normalized Earnings Yield | -21.57 |